
Powders, capsules, gummies, drinks, coffee creamers: collagen has become the wellness industry's most bankable protein. The promise is seductive. You are promised a smoother skin, healthier joints, stronger hair, better gut health. Just add a scoop to your morning coffee.
Here is the problem with that. When you swallow collagen, your digestive system does what it does to every protein: it breaks it down. Your body does not absorb collagen molecules intact and shuttle them to your skin like a targeted delivery service. It breaks them into smaller pieces such as amino acids, dipeptides, and tripeptides. Then uses them wherever they are needed most. That might be your skin. It might be wound healing. It might be your liver.
This does not mean collagen supplements are useless. But it does mean the picture is considerably more complicated than the supplement industry wants you to believe. The evidence is genuinely mixed. A landmark 2025 meta-analysis, that has been challenged here and elsewhere, revealed something uncomfortable about the research that made collagen famous in the first place.
Collagen is the most abundant protein in the human body, accounting for roughly one-third of your total protein mass. It provides structural support for skin, bones, tendons, cartilage, and blood vessels. There are at least 28 types of collagen in humans, though types I, II, and III make up the vast majority. Type I dominates in skin and bones. Type II is concentrated in cartilage. Type III supports blood vessels and organs.
When collagen supplements are marketed as 'hydrolysed collagen' or 'collagen peptides,' this means the protein has been pre-broken into smaller fragments to improve absorption. And this matters, because intact collagen is a large, tightly wound triple-helix molecule that resists digestion and is poorly absorbed.
Hydrolysed collagen, by contrast, gets broken down further by your stomach acid and digestive enzymes into its component amino acids and small peptides: predominantly glycine, proline, and hydroxyproline, which together account for roughly 57% of collagen's total amino acid content [1].
For years, the conventional wisdom was straightforward: you swallow collagen, your gut breaks it into individual amino acids, and those amino acids enter the general pool. End of story. Your body uses them wherever it needs protein, which might have nothing to do with your skin.
Recent research has complicated that picture in an important way. A 2024 randomised crossover study published in Frontiers in Nutrition showed that after ingesting 10 grams of collagen hydrolysate, the amount of hydroxyproline-containing peptides in participants' blood was significantly higher than the amount of free hydroxyproline alone, regardless of collagen source or molecular weight [2]. This means collagen is not entirely reduced to single amino acids during digestion. A meaningful fraction survives as dipeptides and tripeptides, small enough to be absorbed, but structurally distinct enough to potentially act as signalling molecules.
The most studied of these is prolyl-hydroxyproline (Pro-Hyp), which reaches micromolar concentrations in the blood after ingestion and has been shown in vitro to stimulate fibroblasts, the cells that produce collagen in your skin [3]. A 2018 rat intestinal perfusion study confirmed that collagen hydrolysate is absorbed predominantly as peptides rather than free amino acids, and these peptides survive first-pass liver metabolism to enter systemic circulation [4].
This is a genuine mechanistic finding. It suggests collagen-derived peptides may have biological activity beyond simply providing raw materials. But, and this is an important distinction, in vitro fibroblast stimulation and measurable blood peptide levels are not the same thing as proven clinical benefit in humans. For that, we need to look at the trials.
If you read the marketing materials or even many of the published meta-analyses, the story looks convincing. A 2023 systematic review and meta-analysis by Pu et al., published in Nutrients, pooled data from 26 randomised controlled trials involving 1,721 participants and found that hydrolysed collagen supplementation significantly improved both skin hydration and skin elasticity compared to placebo [5]. A separate 2023 meta-analysis in Cureus covering 14 RCTs and 967 patients found similar results across both fish-derived and non-fish collagen sources [6].
Supplement durations in these trials ranged from 4 to 12 weeks. Doses ranged from 1 to 10 grams per day. Most participants were women aged 25-65. On the surface, it looks like a robust and growing body of evidence.
The catch:
In May 2025, a meta-analysis published in The American Journal of Medicine: by researchers at Korea's National Cancer Center with no industry funding and no conflicts of interest did something no previous collagen meta-analysis had done. It analysed the same body of RCTs but stratified results by funding source and study quality [7].
The findings were striking. Myung and Park analysed 23 RCTs involving 1,474 participants. When all studies were pooled together, collagen supplements showed significant improvements in skin hydration, elasticity, and wrinkles. That is consistent with previous meta-analyses. But when they separated the studies by who paid for them, the picture inverted.
Studies funded by collagen manufacturers showed significant skin benefits. Studies without industry funding showed no significant effect on skin hydration, elasticity, or wrinkles.
The same pattern emerged when studies were stratified by methodological quality. High-quality studies, assessed using the Cochrane Risk of Bias 2.0 tool, showed no significant effect in any skin category. Low-quality studies showed a significant improvement in elasticity. The authors' conclusion was direct: there is currently no clinical evidence to support the use of collagen supplements to prevent or treat skin aging.
This does not mean the supplement definitely does not work. It means the evidence that it does is almost entirely generated by the companies selling it. That is a meaningful distinction, and it is one that the collagen industry, predictably, disputed. A 2025 letter to The American Journal of Medicine from independent researchers noted that a significant number of studies reporting favourable outcomes are sponsored by or affiliated with commercial entities, and called for independently funded RCTs [8].
The collagen industry's response pointed to potential misclassifications: arguing that some studies labelled 'non-funded' were actually internal R&D trials from collagen manufacturers [9]. If anything, that reinforces the concern: when even the supposedly 'independent' studies may have commercial ties, the evidence base is even weaker than it appears.
If you are taking collagen primarily for your skin, you should know that the strongest-looking evidence comes from the people who profit from your purchase. That does not make it wrong, but it should make you more cautious than the Instagram ads suggest.
Aniva's approach to supplementation starts with measurement, not marketing. If you are supplementing collagen, or anything else, for skin, energy, or inflammation, testing the biomarkers that actually reflect what is changing tells you more than any label ever will. Aniva's annual panel includes inflammation markers like hs-CRP, amino acid-relevant markers, and nutrient cofactors like vitamin C and zinc for EUR 199/year. Processed at an ISO 15189-certified German or Finnish laboratory near you.
Sign up for a membership here.
The joint evidence is genuinely more compelling than the skin data, and less entangled with the funding problem.
A 2024 trial sequential meta-analysis published in Osteoarthritis and Cartilage, the journal of the Osteoarthritis Research Society International, analysed 35 RCTs involving 3,165 patients with osteoarthritis. It found that collagen derivatives produced small-to-moderate effects on pain reduction (moderate certainty evidence) and functional improvement (high certainty evidence) compared to controls [10]. Trial sequential analysis confirmed the results were unlikely to be overturned by future studies.
A separate 2024 meta-analysis by Simental-Mendia et al. focused specifically on knee osteoarthritis across 11 RCTs and 870 participants and found significant improvements in both function and pain scores [11].
The effect sizes here are modest: comparable to glucosamine and chondroitin, not to anti-inflammatory drugs. But for a supplement with a favourable safety profile and no serious adverse effects reported across dozens of trials, 'modest but real' is a reasonable description of the joint evidence.
It is worth noting that the joint evidence involves two distinct types of collagen supplements working through entirely different mechanisms. Hydrolysed collagen (types I and II) provides raw materials, amino acids and peptides, that may support cartilage repair. Undenatured type II collagen (UC-II), taken in very small doses of around 40 mg per day, works through a completely different pathway: oral tolerance. By exposing the gut immune system to intact type II collagen, it may reduce the autoimmune attack on cartilage that drives inflammatory joint disease. The mechanisms are as different as fuelling a car and reprogramming its navigation system.
If you are considering collagen for joint health, this distinction matters. Hydrolysed collagen is typically dosed at 5-10 grams daily. Undenatured type II collagen at 40 mg. They are not interchangeable.
A 2024 systematic review in the Deutsche Zeitschrift fur Sportmedizin examined 13 RCTs on collagen peptide supplementation and musculoskeletal performance in healthy adults. The conclusion: collagen supplementation had no significant impact on short-term recovery or long-term adaptation of musculoskeletal performance parameters [12]. Out of 31 paired data sets, 28 showed no difference between collagen and placebo groups.
This should not be surprising. Collagen is an incomplete protein, it lacks tryptophan entirely and is low in branched-chain amino acids (leucine, isoleucine, valine), which are the primary drivers of muscle protein synthesis. If your goal is muscle building or athletic performance, whey, casein, or even a well-planned plant-based protein source will deliver meaningfully more of the amino acids your muscles actually need. Collagen is not a substitute for complete protein, no matter what the packaging implies.
Aniva's annual biomarker panel tracks markers directly relevant to athletic performance and recovery. Including inflammatory markers, kidney function markers like creatinine and eGFR, and hormones like cortisol and testosterone. If you are training seriously, these numbers tell you far more about your body's response to training than any supplement label.
Sign up for a membership here.
Here is something the collagen industry rarely emphasises adequately: your body cannot synthesise collagen without vitamin C. Ascorbic acid is a required cofactor for prolyl hydroxylase and lysyl hydroxylase, the enzymes that stabilise the collagen triple helix. Without adequate vitamin C, collagen synthesis stalls regardless of how many peptides are floating around in your bloodstream.
This is not theoretical. It is the mechanism behind scurvy, which is, at its core, a disease of collagen collapse. And while clinical scurvy is rare in modern Europe, suboptimal vitamin C status is not. Smokers, people under chronic stress, and those with limited fruit and vegetable intake may have levels that are sufficient to prevent scurvy but insufficient to support optimal collagen turnover.
If you are spending EUR 30-60 per month on collagen supplements but have never checked your vitamin C, zinc, or iron status, all of which play roles in collagen metabolism, you may be addressing the wrong variable entirely. This is the broader problem with supplement-first thinking: it starts with the product, not with your body's actual needs. We have written about this same pattern with vitamin D, supplementing without testing is supplementing blind.
Based on the current evidence, there are a few groups for whom collagen supplementation has a reasonable argument behind it. People with diagnosed osteoarthritis, particularly of the knee, where multiple meta-analyses show modest but consistent improvements in pain and function with 5-10 grams of hydrolysed collagen daily over 3-6 months.
Older adults experiencing age-related collagen decline, especially if they have low dietary protein intake or poor protein variety, collagen provides glycine, proline, and hydroxyproline in proportions not easily obtained from other protein sources. People with specific connective tissue needs like tendon injuries, wound healing, or post-surgical recovery, where early-stage evidence suggests collagen peptides combined with vitamin C may support tissue repair.
A fascinating 2025 study published in npj Aging found that supplementation with the collagen amino acid ratio of 3 glycine : 1 proline : 1 hydroxyproline reduced biological age by 1.4 years over six months in a clinical observational trial, though this was a small study and needs replication [13].
If you are a generally healthy person under 40 taking collagen primarily for skin benefits, the independent evidence does not currently support the expense. If your diet already includes adequate protein from varied sources: meat; fish; eggs; dairy or legumes - you are likely already providing your body with the amino acids it needs for collagen synthesis.
If you are spending on collagen but neglecting cofactors: vitamin C; zinc; copper, you are probably limiting your own collagen production more than any supplement can fix.
Finally, if you are a vegetarian or vegan, then there are bad news. Almost all current collagen supplements we have reviewed are animal-derived. Vegan 'collagen boosters' typically contain vitamin C and amino acid precursors but no actual collagen or collagen peptides. They are a fundamentally different product, despite the marketing.
The collagen market has a transparency problem that extends beyond funding bias in clinical trials. Most collagen supplements do not disclose their amino acid profiles on the label.
Making it impossible to verify whether you are getting a meaningful amount of the specific peptides shown to be bioactive in research. Doses in studies range from 2.5 to 15 grams per day, yet many retail products contain far less per serving. Source matters: fish, bovine, and chicken collagen have different amino acid compositions. But many products do not specify the collagen type, source species, or molecular weight. And 'collagen' in your coffee creamer, protein bar, or gummy is not the same as the hydrolysed collagen peptide used in clinical trials.
The regulatory landscape does not help. In the EU, collagen supplements fall under the general food safety framework, not pharmaceutical regulation. They do not require proof of efficacy before sale.
This is the paradox of the supplement industry: it funds the research, markets the results, and sells the product. While operating in a regulatory space that does not require it to prove any of it works.
If you choose to take collagen supplements, and that is a reasonable personal decision, especially for joint health, then the question becomes: how do you know if it is doing anything?
Your mirror is a poor measuring instrument. Skin changes are slow, subjective, and confounded by everything from hydration to sleep to sun exposure to seasonal humidity. What is measurable is the internal environment that determines whether supplementation is actually shifting anything meaningful.
Inflammation markers like hs-CRP is a good first pick. If collagen is reducing joint inflammation or systemic inflammatory load, this number should reflect it over time. Nutrient cofactors can be a reasonable secondary metric. Ones such as vitamin C, zinc, copper, and iron status. All play roles in collagen synthesis and can be tested directly. Metabolic and hormonal markers can be a third option cortisol, fasting insulin, thyroid function. These affect tissue repair and turnover in ways that no supplement can override if the underlying levels are off.
Testing does not replace supplementation. But it does tell you whether your body is actually in a position to use what you are giving it, and whether anything is changing as a result. That is the difference between data-driven supplementation and expensive guesswork.
Aniva's annual panel includes 100+ biomarkers. Covering inflammation, nutrient status, metabolic health, and hormones. So you can track what is actually changing in your body, not just what a supplement label promises. One blood draw, one comprehensive report, one clear picture. For EUR 199/year.
Sign up for a membership here.
Collagen is not snake oil. The digestion story is more nuanced than 'your stomach just destroys it' because bioactive peptides do survive and reach the bloodstream. The joint evidence, particularly for osteoarthritis, is modest but real across multiple independent analyses. And the amino acid profile of collagen is genuinely unique. Glycine, proline, and hydroxyproline are not easily obtained in these proportions from other dietary sources.
But the skin evidence, which is the primary reason most people buy collagen, rests on a foundation that crumbles under scrutiny. When you remove industry-funded studies and low-quality trials, the effect disappears. That is not proof of no effect. It is proof that we do not yet have clean evidence of an effect. There is a difference. But it is an important one if you are spending EUR 30-60 per month on a supplement.
If you are going to take collagen, take it for the right reasons, at the right dose, with the right cofactors, and with realistic expectations. And if you genuinely want to know whether it or anything else is working, measure what is actually changing.
That is what testing is for.
[1] Li P, et al. Amino Acids, 2018;50(1):29-38. Source
[2] Osawa Y, et al. Frontiers in Nutrition, 2024. Source
[3] Taga Y, et al. npj Science of Food, 2022;6:29. Source
[4] Osawa Y, et al. Biomedical Research, 2018;39:1-11. Source
[5] Pu SY, et al. Nutrients, 2023;15(9):2080. Source
[6] Dewi DAR, et al. Cureus, 2023;15(12):e50231. Source
[7] Myung SK, Park Y. The American Journal of Medicine, 2025;138(9):1264-1277. Source
[8] Silva CIM, Rezende AL. The American Journal of Medicine, 2025. Source
[9] Rajan R, Divyalakshmi C. The American Journal of Medicine, 2025. Source
[10] Lin CW, et al. Osteoarthritis and Cartilage, 2024;32(4):443-453. Source
[11] Simental-Mendia M, et al. Clinical and Experimental Rheumatology, 2024. Source
[12] Kirmse M, et al. Deutsche Zeitschrift fur Sportmedizin, 2024;75:179-188. Source
[13] Van der Kruk T, et al. npj Aging, 2025;11:35. Source
This content is for informational purposes only and is not medical advice. Collagen supplements may interact with individual health conditions and medications. Always discuss supplementation decisions with a qualified healthcare professional, particularly if you have kidney disease, allergies to animal-derived products, or are pregnant or breastfeeding.